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Trithorax proteins and long-intergenic noncoding
RNAsarecritical regulatorsof embryonicstemcell plu-
ripotency; however, how they cooperatively regulate
germ layer mesoderm specification remains elusive.
We report here that HoxBlinc RNA first specifies
Flk1+ mesoderm and then promotes hematopoietic
differentiation through regulation of hoxb pathways.
HoxBlinc binds to the hoxb genes, recruits Setd1a/
MLL1 complexes, andmediates long-range chromatin
interactions to activate transcription of the hoxb
genes. Depletion of HoxBlinc by shRNA-mediated
knockdown or CRISPR-Cas9-mediated genetic dele-
tion inhibits expression of hoxb genes and other fac-
tors regulating cardiac/hematopoietic differentiation.
Reduced hoxb expression is accompanied by
decreased recruitment of Set1/MLL1 and H3K4me3
modification, as well as by reduced chromatin loop
formation. Re-expression of hoxb2–b4 genes in
HoxBlinc-depleted embryoid bodies rescues Flk1+
precursors that undergohematopoieticdifferentiation.
Thus, HoxBlinc plays an important role in controlling
hoxb transcriptionnetworks thatmediatespecification
of mesoderm-derived Flk1+ precursors and differenti-
ation of Flk1+ cells into hematopoietic lineages.INTRODUCTION
The homeobox-containing Hox genes are critical for body
patterning and lineage determination during embryogenesis
(Chambeyron et al., 2005; Pindyurin and van Steensel, 2012). InCmammals, Hox genes are clustered in four chromosomes and
reveal coordinated expression pattern during development.
Theyare regulatedbyacombinationof long-intergenic noncoding
RNAs (lincRNAs) and trithorax (TrxG)/polycomb (PcG) complexes
(Brock et al., 2009;Denget al., 2013;Rinnet al., 2007; Soshnikova
andDuboule, 2009). For example,HOTAIR suppresses transcrip-
tion of theHoxD locus in trans by targeting the polycomb-repres-
sive complex 2 (PRC2) and the H3K4 demethylase LSD1 to this
locus (Tsai et al., 2010). In theHoxA locus, two lincRNAs,HOTTIP
andMistra, control transcription ofHoxA genes by recruitingMLL
H3K4 histone methyltransferase (HMT) complexes (Bertani et al.,
2015; Wang et al., 2011). Recent studies revealed that dozens of
ESC-expressed lincRNAs maintain the ESC pluripotency by
acting as regulatory circuitries of ESC gene expression programs
(Guttman et al., 2011). The fact that lincRNAs are promiscuously
associated with PRC2 suggests that many lincRNAs may play a
dominant role in maintaining general repressive chromatin states
(Davidovichet al., 2013;Khalil et al., 2009).Despite these findings,
the role of lincRNAs in the regulation of chromatin dynamics and
activation of Hox gene expression patterns during lineage differ-
entiation remains poorly understood.
During embryonic development, several signaling pathways
specify mesoderm and hematopoietic fates of ESCs (Blank
et al., 2008; Lengerke et al., 2008; Trompouki et al., 2011). Coor-
dination of these pathways induces mesoderm patterning and
specification by activating Cdx/Hox genes (Lengerke et al.,
2008). Collinear activation of HoxB genes causes epiblast pre-
cursors to migrate into the primitive streak for mesoderm spec-
ification (Iimura and Pourquie´, 2006). Both cardiogenic and
hemangiogenic progenitors are developed from mesoderm-
derived Flk1+ cells (Chan et al., 2013; Liu et al., 2012).
The temporal expressionofhoxbgenes is regulatedbydynamic
chromatin reorganization in nuclei (Chambeyron and Bickmore,
2004). Upon retinoic acid (RA)-induced ESC differentiation, hoxb







Figure 1. HoxBlinc Specifies Flk1+ Meso-
dermal Cells
(A) Expression of HoxBlinc negatively correlates
with Oct4 expression during EB hematopoietic
differentiation.
(B) Expression of hoxb genes was gradually
induced upon EB differentiation.
(C) Northern blot analysis of HoxBlinc RNA was
performed in ESCs and day 6 EBs with or without
Dox-induced HoxBlinc KD.
(D) FACS analysis of Flk1+ cells in induced
HoxBlinc KD and control EBs. KD was induced at
the day 2 epiblast stage, and FACS analysis was
carried out at day 4 of EB differentiation.
(E) BL-CFC potential of EBs with or without Dox-
induced HoxBlinc KD at day 2 epiblast stage.
(F) FACS analysis of CD31+/CD41+ endothelial/
hematopoietic cells differentiated from the induced
HoxBlinc KD at day 2 epiblast stage and control
blast colonies.
(G) RNA-seq analysis of induced HoxBlinc KD
(+Dox) and control EBs (Dox) at epiblast stage
(day 2). RNA was isolated from day 6 differentiated
EBs. HoxBlinc-RNA-regulated genes were anno-
tated by Gene Ontology (GO) analysis.
(H) Overlap between HoxBlinc-RNA-activated
genes and total ESC bivalent genes.(CTs) for expression whereas silent genes remain located within
dense CTs (Chambeyron et al., 2005). Recent studies revealed
that the anterior HoxB genes, B2, B3, B5, and B6, are dependent
onMLL1 for activation (Liu et al., 2011). In contrast,HoxB4 is regu-
lated by the Setd1a complex (Deng et al., 2013). Themechanisms
by which specific Set1/MLL proteins are targeted to specific
HoxBgene loci to introduceactiveH3K4methylationpatterns, co-
ordinate three-dimensional (3D) chromatin domains, and initiate
differentiation of particular cell lineages remain elusive.
Here,wediscovered a hoxb locus-associated lincRNA, termed
HoxBlinc, that regulates hoxb gene transcription by modulating
local chromatin alterations. Inhibition of HoxBlinc resulted in a
block of early cell lineage commitment by perturbing specifica-
tion of mesoderm-derived Flk1+ precursors and by subsequently
inhibiting hematopoietic differentiation of Flk1-expressed cells.
Furthermore, HoxBlinc RNA recruits Setd1a/MLL1 complexes
and facilitates the organization of a specific 3D chromatin archi-104 Cell Reports 14, 103–114, January 5, 2016 ª2016 The Authorstecture that activates the anterior hoxb
genes, resulting in cardiogenic/hemo-
genic mesoderm differentiation.
RESULTS
The Expression of HoxBlinc Is
Positively Correlated with Anterior
hoxb Gene Transcription Upon EB
Differentiation
hoxb genes play a critical role in he-
matopoietic development (Abramovich
and Humphries, 2005). We identified a
2.57-Kb noncoding region upstream ofthe hoxb4 gene that is actively transcribed upon differentiation
of R1/E ESCs into EBs (Figure 1A). Expression of this transcript
positively correlates with a gradual increase in the expression
of anterior hoxb genes (Figures 1A and 1B), suggesting a poten-
tial role of this lincRNA in hoxb gene activation. We defined this
lincRNA as HoxBlinc because it is located at the hoxb locus and
co-expressed with hoxb genes. We further employed 50- and
30-RACE-PCR using cDNA prepared from day 6 differentiated
EBs to clone the full-length HoxBlinc, which is 2,571 nucleotides
long and lacks introns (Figure S1A). Its transcription start site
(TSS) is located 2,638 bp upstream of the TSS of the hoxb4
gene on mouse chromosome 11 (Figure 1A).
HoxBlinc RNA Regulates Key Genes Required for Early
Lineage Commitment
To delineate the role of HoxBlinc in embryonic development, we
created two Tet-ON-Dox-inducible HoxBlinc shRNA ESC clones
that allowed specific knockdown (KD) of HoxBlinc at two distinct
stages of EB differentiation, at the epiblast cell stage at day 2 and
Flk1+ mesodermal stage at day 3.5. Northern blotting and RT-
PCR analysis demonstrated that the 2.57-KbHoxBlinc transcript
is silenced in ESCs and induced upon EB differentiation (Figures
1C and S1B). KD of HoxBlinc at the ESC or EB (day 2) stages
affected neither pluripotency and expression of stemness genes,
e.g., OSKM (Figures S1C and S1D), nor cell-cycle progression
upon EB differentiation (Figure S1E). The transcript levels of
HoxBlinc RNA, anterior hoxb genes, and mesodermal/endo-
dermal marker genes were significantly inhibited in differentiated
EBs (Figures 1C, S1F, and S1G). During differentiation, murine
ESCs differentiate into Flk1+ cells capable of generating a blast
colony consisting of hematopoietic and endothelial cells (Ken-
nedy et al., 1997) at day 3. KD of HoxBlinc using two different
inducible shRNAs at the epiblast stage (day 2) resulted in a sig-
nificant reduction of Flk1+ cells from an average of 49.2% to
average of 6.9% (Figure 1D shows the result of one experiment;
Figure S1H shows the average of three independent experi-
ments). Furthermore, we found that KD of HoxBlinc at the
epiblast stage blocked formation of blast colonies (Figure 1E)
and CD31+ endothelium cells (Figure 1F).
RNA-seq analysis was carried out to elucidate the role of
HoxBlinc RNA in EB differentiation by comparing differentiated
day 6 EBs that express or silence HoxBlinc at an early stage.
A total of 539 genes showed a more than 3-fold decrease in
mRNA levels whereas only 51 genes increased expression
upon HoxBlinc KD (Tables S1 and S2), suggesting that HoxBlinc
RNAmainly functions as a transcriptional activator during EB dif-
ferentiation. Among the affected genes, cdx2 and hoxb2–4
genes were decreased by more than 3-fold (Tables S1 and
S2). Gene Ontology (GO) analysis revealed that the pathways
specifically affected by HoxBlinc KD are those involved in cell
fate commitment, epithelial to mesenchymal transition, and
anterior/posterior patterning, which are linked to Hox gene func-
tion in early embryogenesis, as well as hematopoietic and car-
diac development (Figure 1G). Furthermore, the pathways that
regulate hemangiogenic/cardiogenic mesoderm differentiation
such as BMP/Wnt signaling and aorta morphogenesis are also
dysregulated upon HoxBlinc KD (Figure 1G). Genes encoding
for early developmental regulators are often associated with
bivalent chromatin marks (H3K4me3 and H3K27me3) and are
in a poised state that maintains lineage commitment programs.
The comparison of bivalentmarkswith gene expression changes
showed that 50%ofHoxBlinc-downregulated genes (269 genes)
are bivalently marked in ESCs (Figure 1H). Interestingly, genes
encoding brachyury (T) or the H3K9 HMT suv39h1 are among
those that are highly upregulated upon KD (Figure 2A). Thus,
HoxBlinc RNA plays a critical role in coordinating anterior hoxb
gene expression during ESC commitment and differentiation to-
ward hematopoietic lineages.
HoxBlinc Regulates Specification of Mesoderm Toward
Hematopoietic Lineages
The Flk1+ cells possess both hematopoietic and cardiac poten-
tials and can be committed to either lineage (Ema et al., 2003;
Kattman et al., 2006). The data in Figure 1G suggest that
HoxBlinc RNA is required for hematopoietic cell fate specifica-Ction. Further analysis of the RNA-seq data revealed that expres-
sion of transcription factors (TFs) or markers critical for the early
onset of hematopoiesis, such as TAL1, LMO2, Lyl1, Meis1, Fli1,
CD34, and bH1, decreased by more than 3-fold upon HoxBlinc
KD (Figures 2A and 2C). The NOTCH-signaling pathway plays
a pivotal role in the development of hematopoietic stem and pro-
genitor cells (HS/PCs) (Bigas and Espinosa, 2012). Ablation of
HoxBlinc RNA led to a significant decrease in genes encoding
components of the NOTCH pathway (Figure 2A, right). Impor-
tantly, GO analysis revealed that hematopoiesis and hemato-
poietic organ development are regulated by HoxBlinc RNA
(Figure 1G).
Loss of HoxBlinc RNA led to a strong decrease in hoxb1-b6
gene expression and that of hematopoietic TF andmarker genes
(Figures 2B, 2C, and S2A). Anterior hoxb genes are critical regu-
lators of early hematopoiesis (Bjo¨rnsson et al., 2003; Magnusson
et al., 2007). Depletion of HoxBlinc did not decrease expression
of the posterior hoxb9 and hoxagenes (Figures 2BandS2B). Dur-
ingEBdifferentiation, Flk1+ hemangiogenicmesodermcontinues
to formblast colonies anddifferentiate intoCD41+/c-Kit+HS/PCs
at day 4 and beyond (Figure 2D; Chung et al., 2002; Kennedy
et al., 1997). Although KD of HoxBlinc at the Flk1+ mesoderm
stage reduced the CD41+/c-Kit+ HS/PCs from an average of
9.03% to 2.88% (Figures S2C and S2D), the effects on hemato-
poiesis could result from the fact that HoxBlinc KD reduced
Flk1+ cells (Figures 1D and S1H). To ensure that HoxBlinc not
only acts on Flk1+ mesoderm formation but also specifies differ-
entiation of Flk1+ cells toward hematopoietic lineages, we FACS
sorted hemangiogenic Flk1+ cells and followed the blast culture.
KD of HoxBlinc using two different inducible shRNAs in purified
Flk1+ cells resulted in a significant reduction of CD41+ HS/PCs
by 56.7% (Figure 2E). In contrast, expression of the scrambled
shRNA had no effect (Figure 2E). Furthermore, KD of HoxBlinc
blocked the differentiation of CD41+ HS/PCs into various
hematopoietic lineages includingGM,GEMM,Ery-D, andmacro-
phages (Figure 2F). Accompanied with inhibition of hematopoie-
sis by HoxBlinc loss, anterior hoxb genes and genes encoding
hematopoietic-specific TFs were also downregulated (Figures
2Gand2H). Thus,HoxBlincRNA is also a crucial regulator of early
hematopoiesis, perhaps by regulating anterior hoxb gene tran-
scription and expression of other important hematopoietic TFs.
HoxBlinc also regulates anterior HOXB genes in human he-
matopoietic cells, which is supported by our observation that
HoxBlinc RNA and anterior HOXB genes are highly expressed
in human erythroleukemia K562 cells. KD of HoxBlinc decreased
anterior HOXB gene expression by downregulating H3K4me3
enrichment at the promoter regions (Figures S2E–S2G). In addi-
tion, loss of HoxBlinc inhibited K562 cell proliferation
(Figure S2H).
HoxBlinc Modulates Cardiac Differentiation by
Regulating hoxb Gene Transcription and Flk1+
Mesoderm Specification
The cardiogenic mesoderm is also derived from Flk1+ cells. Four
important TFs, Isl1, Nkx2.5, Mef2c, and Gata4, are critically
involved in the differentiation of cardiac mesoderm (Chan
et al., 2013; Olson, 2006; Watanabe and Buckingham, 2010).






Figure 2. HoxBlinc Controls Hematopoietic
Differentiation by Regulating hoxb Genes and
Hematopoietic Transcription Programs
(A) Scatterplots showing that expression levels of
TFs and those encoding genes required for hema-
topoiesis (left) or the NOTCH pathway (right). Acti-
vated genes are shown in red, repressed genes in
blue (only genes are shown that alter expression by
more than 3-fold upon HoxBlinc KD).
(B) qRT-PCR analysis of hoxb gene expression
comparing induced HoxBlinc KD (+Dox) and control
EBs (Dox) at day 6.
(C) qRT-PCR analysis of expression of genes en-
coding key hematopoietic TFs and markers in
induced HoxBlinc KD (day 3 Flk1+ stage) and control
EBs collected at day 6.
(D) Schematic representation of hematopoietic dif-
ferentiation from the purified FLK1+ cells following
hemangioblast development.
(E) FACS analysis of CD41 expression upon he-
matopoietic differentiation of sorted FLK1+ cells,
which were then induced for HoxBlinc KD and
cultured in blast culture media.
(F) CFC analysis of definitive hematopoietic colonies
(Ery-D, GEMM, GM, and Mac) in induced HoxBlinc
KD and control EB-derived cells.
(G) qRT-PCR analysis of hoxb gene expression upon
hematopoietic differentiation of sorted FLK1+ cells
that were then induced for HoxBlinc KD and cultured
in blast culture media.
(H) Analysis of the expression of hematopoietic-
specific TFs and markers during hematopoietic dif-
ferentiation of sorted FLK1+ cells with and without
HoxBlinc KD cultured in blast culture media. Data are
presented as mean ± SD from three or four inde-
pendent experiments; *p < 0.05; **p < 0.01 by Stu-
dent’s t test.than 3-fold decrease in expression of these important regulators
(Figures 3A and 3B). Consistently, expression of other TFs
important for heart development such as Hand1, Hand2, and
Tbx5 was also drastically decreased (Figures 3A and 3B).
Next, we examined whether HoxBlinc is important for the for-
mation of cardiogenic mesoderm and cardiac lineage specifica-
tion. KD of HoxBlinc led to a strong reduction in the formation of
Flk1+/PDGFRa+ cardiogenic mesoderm cells (Figure 3C). The
number of Flk1+/PDGFRa+ cells was reduced from an average
of 32.75% without Dox to an average of 12.9% with Dox induc-
tion (Figures 3C and S3A). The cardiomyocytic markers cTnT
and actc1 are also inhibited by the HoxBlinc KD (Figure 3D).
Depletion of HoxBlinc prevented formation of contracting cardi-
omyocytes that exhibited spontaneous beating (Movies S1 and
S2). Furthermore, when we silenced HoxBlinc in CGR8 MHC-
GFP ESCs, which harbor a GFP gene driven by the cardiac line-106 Cell Reports 14, 103–114, January 5, 2016 ª2016 The Authorsage tracer MHCa chain promoter (Singh
et al., 2007), we observed a decrease in
GFP+ EBs from 33% in WT cells to only
7% upon Dox-induced HoxBlinc KD (Fig-
ures 3E and S3B). The reduction in the
number of GFP-expressing cells was
accompanied by reduced expression ofthe cTnT and actc1 genes (Figure S3C). To distinguish whether
the effect is due to blocking of Flk1 mesoderm specification or
later cardiac differentiation, we FACS sorted hemangiogenic
Flk1+ cells, induced HoxBlinc KD, and followed cardiomyocytic
differentiation. Depletion of HoxBlinc using two different induc-
ible shRNAs in purified Flk1+ cells did not affect the ability of
Flk1+ cells to differentiate and express cardiomyocytic markers
cTnT and actc1 (Figures S3D and S3E), indicating that HoxBlinc
regulates cardiomyocytic differentiation by modulating hoxb
gene expression and Flk1+ mesoderm specification.
Re-expression of hoxb2–4 Genes Rescues
Hematopoietic Differentiation in HoxBlinc-
Deficient ESCs
We further addressed whether HoxBlinc-RNA-mediated




Figure 3. KD of HoxBlinc Inhibits hoxb Gene
Expression and Cardiogenic Mesoderm For-
mation
(A) Scatterplot showing expression levels of genes
encoding TFs and markers important for heart
development increased (red) or decreased (blue) by
more than 3-fold upon HoxBlinc KD.
(B) qRT-PCR analysis of expression of genes en-
coding TFs and markers important for heart
development in induced HoxBlinc KD (at the
epiblast stage) and control EBs (Dox) collected at
day 4 and day 6. Data are presented as mean ± SD
from three or four independent experiments; *p <
0.05; **p < 0.01.
(C) FACS analysis of Flk1+/PDGFRa+ cells in
induced HoxBlinc KD (at the epiblast stage) and
control EBs collected at day 4.
(D) qRT-PCR analysis of the expression of cTnT
and actc1 inHoxBlincKD and control EBs collected
at days 0, 4, 7, and 10.
(E) Green fluorescence visualization of the expres-
sion of the cardiomyocyte marker, MHC-GFP, in
induced HoxBlinc KD (at the epiblast stage) and
control EBs (Dox) at day 12.Flk1+ hemangiogenic mesoderm and lineage specification.
We re-expressed the hoxb2–b4 genes, which play an impor-
tant role in hematopoietic development (Bjo¨rnsson et al.,
2003; Krumlauf, 1994; Magnusson et al., 2007) in the HoxBlinc
KD ESCs. Expression of hoxb2–b4 in the HoxBlinc KD
cells (Figure 4A) partially rescued Flk1+ precursors at day 4
on average (three experiments) from 4.7% in HoxBlinc KD
cells to 22.03% in rescued cells (Figures 4B and 4C, top)
and c-Kit+/CD41+ HS/PCs at day 6 on average (three experi-
ments) from 2.85% in KD cells to 4.85% in rescued cells
(Figures 4B and 4C, bottom). Importantly, expression of
hoxb2–b4 genes did not affect the KD efficiency of HoxBlinc
RNA (Figure 4A). Furthermore, expression of hoxb2–b4 genes
in the HoxBlinc KD cells partially rescued hemangioblast col-
onies (Figure 4D) and differentiation into various hematopoietic
colonies including GM, GEMM, and Ery-D (Figure 4E). To
further confirm the role of HoxBlinc in Flk1 mesoderm specifi-
cation, we expressed full-length HoxBlinc in WT ESCs and al-
lowed them to differentiate. Expression of HoxBlinc enhancedCell Reports 14, 103–11the Flk1+ mesodermal cell population at
day 4 of EBs (Figure S3F).
Hematopoiesis is a coordinated process
that requires theactionofmanyhematopoi-
etic TFs and signaling pathways. We
reasoned that expression of hoxb2–b4
genes in the HoxBlinc KD cells might reac-
tivate key hematopoietic TFs and markers
inhibited by the HoxBlinc KD. To address
this, we analyzed the expression levels of
tal1, lmo2. fli1,cdx2, andbh1 in theWTcon-
trol, HoxBlinc KD, and rescued cells. Re-
expression of hoxb2–b4 led to a significant
increase in expression levels of these he-
matopoietic TFs and markers comparedto the HoxBlinc KD cells (Figure 4F). Furthermore, re-expression
of hoxb2–b4 also rescued the expression of genes encoding
components of the NOTCH pathway (Figure 4G) consistent with
the roleof theNOTCHpathway inHSC functionandhematopoietic
development (Benveniste et al., 2014). Thus, these data revealed
a molecular pathway by which HoxBlinc regulates hemato-
poietic transcription networks and the NOTCH signaling by con-
trolling transcription of the anterior hoxb genes during early
hematopoiesis.
HoxBlinc Directly Recruits Setd1a/MLL1 HMTs to
Activate Transcription
Next, we sought to understand the mechanism(s) by which
HoxBlinc regulates hoxb genes. We performed chromatin immu-
noprecipitation (ChIP) analysis to examine whether HoxBlinc KD
affects chromatin structure in the hoxb cluster. HoxBlinc KD led
to a broad decrease in H3K4me3 across hoxb1–b6 genes, but
not in the posterior hoxb9 gene (Figure 5A), indicating that







Figure 4. Re-expression of Anterior hoxb2–
b4 Genes Rescues Flk1+ Mesoderm and
HS/PCs in the HoxBlinc KD EBs
(A) qRT-PCR analysis showing expression levels of
HoxBlinc (left) and hoxb2–b4 (right) genes in control
or induced HoxBlinc KD EBs rescued with the
vector or constructs expressing hoxb2–b4 genes.
(B) FACS analysis of Flk1+ cells (top) and CD41+/
c-Kit+ HS/PCs (bottom) in control and induced
HoxBlinc KD EBs rescued with vector or constructs
expressing the HoxB2–B4 genes.
(C) Percentage of Flk1+ cells (top) and CD41+/c-Kit+
HS/PCs (bottom) in control and rescued EBs.
(D) BL-CFC potential of EBs in control or induced
HoxBlinc KD EBs rescued with the vector or con-
structs expressing hoxb2–b4.
(E) Secondary hematopoietic CFC assays of
definitive hematopoietic colonies (Ery-D, GEMM,
and GM) in induced HoxBlinc KD and rescued EBs-
derived blast colony cells.
(F and G) qRT-PCR analysis showing expression
levels of TFs and markers required for hematopoi-
esis (F) or genes encoding NOTCH pathway in
control or rescued EBs (G). Data are presented as
mean ± SD from three or four independent experi-
ments; *p < 0.05; **p < 0.01 by Student’s t test.transcriptionally active hoxb genes. The Set1/MLL complexes
maintain H3K4 methylation patterns at the Hox gene loci and
play important roles in hematopoiesis (Deng et al., 2013; Ernst
et al., 2004; Liu et al., 2011). We examined the association of
HoxBlinc with Set1/MLL complexes using biotin-labeled Hox-
Blinc RNA to pull down Setd1a protein from day 6 differentiated
EB nuclear extracts (NEs) (Figure 5B). Only purified biotinylated
HoxBlinc RNA, but not lRNA, gapdh RNA, or antisenseHoxBlinc
RNA, retrieved Setd1a from differentiated EB NEs, and the inter-
action was mediated by a 30 segment of the HoxBlinc RNA (Fig-
ure 5B). Furthermore, only Setd1a and MLL1 specifically inter-
acted with HoxBlinc RNA, but not other core components of
the Set1/MLL complexes, such as ASH2L and RBBP5, or
LSD1 (Figure S4A). RNA immunoprecipitation experiments using
day 3 EB (before Flk1 formation) or day 6 EB (after Flk1 formation)
NEs confirmed that antibodies against Setd1a and MLL1 specif-
ically pulled down endogenous HoxBlinc RNA at both Flk1 spec-108 Cell Reports 14, 103–114, January 5, 2016 ª2016 The Authorsification and hematopoietic cell stages
(Figure 5C). Both Setd1a and MLL1
contain a highly conserved catalytic SET
domain, which interacts with the N-termi-
nal tails of histone H3 and other chromatin
regulators (Katsani et al., 2001; Rozen-
blatt-Rosen et al., 1998). We tested
whether HoxBlinc associates with both
H3K4 HMT complexes by interacting
with the SET domain. We purified GST-
fusion proteins containing SET domains
of Setd1a or MLL1 and incubated them
with in-vitro-transcribed HoxBlinc RNA or
a control usf1 RNA. Compared to the
GST control, the SET domains of bothSetd1a and MLL1 specifically interacted with HoxBlinc, but not
with usf1 RNA (Figure 5D). The results confirm that HoxBlinc
RNA directly interacts with the SET domains of the Set1/MLL
complexes.
To ascertain whether HoxBlinc RNA activates transcription
through recruiting the Set1/MLL complexes, we employed a
BoxB-tethering reporter system in which BoxB-HoxBlinc RNA
binds to lN fused to the GAL4-DNA-binding domain to regulate
a UAS-driven luciferase reporter gene (Figure 5E; Wang et al.,
2011). The BoxB-HoxBlinc specifically stimulated transcription
of the luciferase gene when compared to the BoxB alone con-
trol (Figure 5E). Strikingly, KD of ASH2L, a component required
for the enzymatic activities of the Set1/MLL1 complexes, spe-
cifically abolished the BoxB-HoxBlinc-RNA-mediated transacti-
vation of the reporter gene (Figure 5E). These data indicate that





Figure 5. HoxBlinc Interacts with the Set1/
MLL1 Complexes to Activate Target Genes
(A) ChIP analysis of H3K4me3 enrichment at pro-
moters of hoxb genes in induced HoxBlinc KD and
control EBs.
(B) Biotinylated HoxBlinc RNA and a 30 domain of
HoxBlinc RNA specifically interact with Setd1a in
6d EB NEs.
(C) RIP showing that both Setd1a and MLL1 are
associated with HoxBlinc before FLK1 specifica-
tion (d3 EBs) and after FLK1 specification (d6 EBs).
(D) HoxBlinc directly interacts with the SET domain
of Setd1a and MLL1 proteins shown by incubating
GST-Setd1aSET or GST-MLL1SET with in-vitro-
transcribed RNAs.
(E) HoxBlinc activates luciferase reporter gene
transcription by recruiting TrxG HMT complexes.
(Top) Diagram of the BoxB-tethering reporter
system in which GAL4-fused lN recruits
BoxB-HoxBlinc fusion RNA-associated TrxG com-
plexes to a UAS-driven luciferase reporter
construct is shown. (Bottom) Luciferase activity
was analyzed 48 hr posttransfection with the indi-
cated constructs. Data are presented as mean ±
SD from three or four independent experiments;
*p < 0.05; **p < 0.01 by Student’s t test.HoxBlincRNA Binds to the hoxb Locus and Is Dependent
on Set1/MLL Complexes for Transcriptional Regulation
and Lineage Differentiation
Next,we testedwhetherHoxBlincdirectly binds to thehoxb locus.
We carried out chromatin isolation by RNA purification (ChIRP)
analysis (Chu et al., 2011) using biotinylated oligonucleotide
probes tiling HoxBlinc RNA, which specifically retrieved HoxBlinc
RNA from chromatin prepared from day 3 and day 6 EBs
comparing to control lacZ probes (Figure 6A). Furthermore,
HoxBlinc RNA specifically interacted with the promoters of
hoxb1–b6 genes, but not with the posterior hoxb9 promoter and
other control regions at both Flk1 specification and hematopoietic
cell stages (Figure 6B).
Consistent with the RIP andChIRP data showing thatHoxBlinc
RNA binds to the promoters of anterior hoxb genes and recruits
Set1/MLL1 complexes (Figures 5 and 6B), ChIP assays revealed
that loss of HoxBlinc specifically decreased recruitment ofCell Reports 14, 103–11Setd1a/MLL1 complexes to promoters of
the hoxb1–b6 genes, but not to the poste-
rior hoxb9 gene or other control regions
at both Flk1 specification and hematopoi-
etic cell stages (Figures 6C, 6D, and
S4B–S4D). The reduced recruitment of
Set1/MLL1 correlated with a decrease
in H3K4me3 levels at the same sites
(Figure 5A).
We further asked whether recruitment
of the Set1/MLL1 complexes is neces-
sary for HoxBlinc-mediated anterior
hoxb gene activation. To test this possi-
bility, we generated Dox-inducible setd1a
and mll1 KD ESCs and analyzed the ef-fects on the coordinated expression of HoxBlinc RNA and ante-
rior hoxb genes upon EB differentiation (Figure S5A). Although
neither setd1a loss nor mll1 KD affected HoxBlinc expression
(Figure S5B), loss of either setd1a or mll1 impaired expression
of anterior hoxb genes, but not expression of the posterior
hoxb9 gene (Figures S5C and S5D). Interestingly, KD of mll1
did not interfere with transcription of the hoxb4 gene (Fig-
ure S5C), which is consistent with previous reports showing
that Setd1a, but not MLL, is required for promoter activation
of the hoxb4 gene (Deng et al., 2013; Liu et al., 2011).
KD of setd1a ormll1 resulted in reduced formation of Flk1+ he-
mangiogenic cells (Figures S5E and S5F) and CD41+/c-Kit+
HS/PCs (Figures S5G and S5H). Notably, the reduction in the
numbers of CD41+ and c-Kit+/CD41+ cells was more pro-
nounced in setd1a KD cells compared to mll1 KD cells (Figures
S5G and S5H), which may be attributed to the ability of Setd1a






Figure 6. HoxBlinc Binds to Anterior hoxb
Genes and Regulates Chromatin Structure
Alterations at the Anterior hoxb Locus
(A) qRT-PCR analysis of RNA retrieved by the
complementary HoxBlinc-tiling probes and LacZ
probes in day 3 and day 6 EBs.
(B) ChIRP analysis of the HoxBlinc RNA enrichment
at the HoxB locus in day 3 and day 6 EBs.
(C and D) ChIP analysis showing binding of Setd1a
(C) and MLL1 (D) at the promoters of hoxb genes in
HoxBlinc KD and control d3 EBs prior to the Flk1
specification.
(E) Schematic diagram representing the cluster or-
ganization of the hoxb genes.
(F) 3C analysis showing interactions between the
HoxBlinc locus and the anterior hoxb genes in ESCs
and differentiated EBs at days 1 and 6.
(G) 3C analysis showing interactions between the
HoxBlinc locus and the anterior hoxb genes in
HoxBlinc KD and control day 6 EBs.
(H) Model depicting how HoxBlinc organizes the
anterior hoxb genes into a CTCF-mediated induc-
ible active chromatin domain that facilitates long-
range interactions between the HoxBlinc locus and
the anterior hoxb1–b3 genes. Data are presented as
mean ± SD from three independent experiments;
*p < 0.05; **p < 0.01 by Student’s t test.2013; Oshima et al., 2011). Nevertheless, these data suggest
that Setd1a and MLL1 mediate HoxBlinc RNA function in spec-
ifying mesoderm development and subsequent hematopoietic
differentiation.
HoxBlinc-Mediated Chromatin Looping Remodels the
hoxb Gene Cluster
Previous studies have shown that chromatin looping estab-
lishes transcriptionally active domains in the hoxb locus (Cham-
beyron et al., 2005). We therefore tested whether HoxBlinc is
required for mediating proximity between the hoxb genes and
the HoxBlinc locus using chromosome conformation capture
(3C) (Figure 6E). All of the EcoRI sites in the hoxb locus were
efficiently digested (Figure S6A). HoxBlinc KD did not change
recruitment of H3K4me1 and p300 enhancer marks to known
hoxb regulatory elements (Figures S6B–S6D). Interestingly,
the HoxBlinc locus was brought into close proximity to the110 Cell Reports 14, 103–114, January 5, 2016 ª2016 The Authorshoxb1, b2, and b3 genes (Figures 6E
and 6F) during differentiation of EBs,
which correlated positively with the acti-
vation of these genes (Figure 1B). The
HoxBlinc locus also interacted with
a +43-Kb element containing a ctcf site
(hoxb1 TSS was set as +1), which may
serve as a boundary to insulate the ante-
rior genes from interfering with other ge-
netic elements in the locus (Figures 6F
and 6H).
Furthermore,KDofHoxBlincsignificantly
decreased looped interactions between
the HoxBlinc locus and individual hoxb1,b2, and b3 genes (Figure 6G). The differentiation-induced
CTCF-mediated active chromatin loop between the 53-Kb
ctcf site and the downstream +43-Kb ctcf site was also disrupted
by HoxBlinc KD (Figures 6E and 6G), indicating that HoxBlinc KD
leads to an impairment of the formation of an active chromatin
domain at the anterior hoxb locus (Figure 6G). Thus, HoxBlinc
RNA is an important regulator for the establishment and mainte-
nance of a 3D active chromatin domain that supports expression
of the anterior hoxb genes during EB differentiation (Figure 6H).
Functional Analysis of the Role ofHoxBlinc in Mesoderm
Differentiation by CRISPR-Cas9-Mediated Genome
Editing
Many lncRNAs are expressed at very low levels, and traditional
RNAi-mediated KD may lead to subtle or inconsistent changes
in gene expression. To provide genetic evidence for a role of







Figure 7. Deletion of the HoxBlinc Locus by
CRISPR-Cas9 Genome Editing Inhibits Flk1+
Mesoderm Differentiation
(A) PCR-based genotyping analysis of the
HoxBlinc genomic KO.
(B) qRT-PCR analysis of HoxBlinc and hoxb gene
expression upon CRISPR-Cas9-mediated deletion
at day 4 EBs.
(C) Immunohistochemistry staining of ectodermal
marker nestin and mesodermal marker a-SMA
comparing WT and HoxBlinc KO teratomas.
(D) qRT-PCR gene expression analysis of three
germ layers in teratomas derived from the control,
HoxBlinc KD, and CRISPR-Cas9-mediated ho-
mozygous HoxBlinc KO.
(E) FACS analysis of Flk1+ cells (left) and CD41+
HS/PCs (right) in control and HoxBlinc KO EBs.
(F–H) qRT-PCR analysis of the expression levels of
TFs (F), markers (G), and Notch-signaling pathway
(H) required for hematopoietic/cardiac differentia-
tion upon CRISPR-Cas9-mediated deletion. Data
are presented as mean ± SD from three in-
dependent experiments; *p < 0.05; **p < 0.01 by
Student’s t test.locus in ESCs using the CRISPR-Cas9 genome-editing system
(Figure 7A). Targeting of Cas9 to the HoxBlinc locus caused a
1,982-bp deletion that encompassed the promoter and the 50 re-
gion of HoxBlinc (Figures S7A, S7B, and 7A) and led to a com-
plete elimination of HoxBlinc RNA expression (Figures 7B and
S7C). Deletion of HoxBlinc did not affect pluripotency of ESCs
(Figure S1C, bottom). However, HoxBlinc loss impaired in vivo
mesoderm formation (Figures 7C and S7E) and the expression
ofmesodermmarkers (Figure 7D). However, expression of endo-
derm markers gata4 and gata6, which are also required for car-
diac mesoderm differentiation, was also affected (Figure 7D).
Consistent with the shRNA-mediated KD, deletion of the
HoxBlinc locus severely impaired specification of Flk1+ heman-
giogenic mesoderm cells and formation of CD41+ HS/PCs (Fig-
ure 7E). Furthermore, the inhibition of mesoderm specification
was accompanied by a strong decrease in anterior hoxb gene
transcription in vitro and in vivo (Figures 7B, S7C, and S7F). AsCell Reports 14, 103–11a result, expression of components of
the NOTCH pathway, TFs, and markers
critical for hematopoietic and cardiac dif-
ferentiation was inhibited by the deletion
of the HoxBlinc locus (Figures 7F–7H
and S7D). Thus, the CRISPR-Cas9-medi-
ated deletion approach confirmed that
HoxBlinc RNA regulates mesoderm spec-
ification by controlling expression of the
anterior hoxb genes.
DISCUSSION
Although lincRNAs play important roles in
a variety of biological processes, such as
innate immunity, heart development, and
maintenance of ESC pluripotency (Gutt-man et al., 2009; Hu et al., 2013; Klattenhoff et al., 2013; Loewer
et al., 2010), it remains unclear how lincRNAs counteract ESC
self-renewal and promote lineage commitment and differentia-
tion. We demonstrate that HoxBlinc RNA specifies hemangio-
genic/cardiogenic mesoderm and promotes development of
HS/PCs by regulating Wnt/NOTCH signaling and Hox pathways.
Blocking of these pathways has two distinct and sequential
effects. It first inhibits mesoderm differentiation and then blocks
mesoderm specification to blood cells (Lengerke et al., 2008).
We show that HoxBlinc RNA serves as a regulator of the
hoxb chromatin loop domain, which subsequently attracts the
positive epigenetic regulators Setd1a and/or MLL1 complexes
to the anterior hoxb genes in order to control both Flk1+ cell
specification and differentiation of Flk1 mesoderm into hemato-
poietic lineages. The detailed dissection of the transcriptional
and signaling pathways affected by HoxBlinc RNA and how
these pathways control early Flk1+ mesoderm and lineage4, January 5, 2016 ª2016 The Authors 111
differentiation has important clinical ramifications for under-
standing hematological/cardiovascular diseases.
Several HoxBlinc RNA targets and/or partners have been
implicated in the regulation of hematopoietic and cardiac stem
cell function. Among them, Notch signaling is a key pathway crit-
ical for both hematopoietic and cardiac development (Benve-
niste et al., 2014; Niessen and Karsan, 2008; Oh et al., 2013).
The RNA-seq analysis of HoxBlinc KD EBs revealed that Notch
signaling is regulated byHoxBlinc RNA (Figure 2A). Furthermore,
hoxb gene rescue experiments demonstrated that hoxb2–b4
genes at least partially mediate Notch pathway regulation by
HoxBlinc during mesoderm specification and hematopoietic dif-
ferentiation (Figure 4G). Thus, consistent with its role in HSC
function, Notch signaling may play a critical role in the
HoxBlinc-mediated specification of mesoderm to hematopoietic
lineages.
The anterior HoxB genes are critical for the specification of
early hematopoietic cell fates and for HSC function (Lawrence
et al., 1996). Both Setd1a and MLL1 have been implicated in
early hematopoiesis through modulating Hox gene transcription
(Deng et al., 2013; Ernst et al., 2004; Liu et al., 2011). In particular,
Setd1a regulates hoxb4 transcription by controlling promoter
H3K4me3 during hematopoietic differentiation (Deng et al.,
2013). Interestingly, a genetic screen in zebrafish identified
Set1 as an important epigenetic regulator of hematopoiesis
(Huang et al., 2013). The role of Set1/MLL complexes in meso-
derm specification toward the blood lineage is consistent with
the role of HoxBlinc in specifying hematopoietic cell fates by
controlling hoxb genes. This notion is supported by the observa-
tion that ectopic hoxb2–b4 gene expression rescued the defects
in the hematopoietic transcription program and in hematopoietic
differentiation observed in the HoxBlinc KD EBs (Figure 4). Thus,
anterior hoxb genes are the key transcription targets and medi-
ators of HoxBlinc RNA action during early hematopoietic cell
fate decisions.
Several cardiovascular differentiation pathways are impaired
by loss of HoxBlinc (Figure 1G). Both hematopoietic and cardio-
vascular lineages originate from mesoderm-derived Flk1+ multi-
potent progenitors (Ema et al., 2003; Kattman et al., 2006),
formation of which requires HoxBlinc and its cofactors Set1/
MLL (Figures 1, 5, and S5). It was recently reported that a lateral
mesoderm-specific lncRNA Fendrr also recruits TrxG com-
plexes to specify the fate of lateral mesoderm derivatives for
heart development in mice (Grote et al., 2013), indicating the
importance of TrxG complexes in specification of Flk1+ meso-
derm. In addition, dynamic expression of hoxb genes also plays
an important role in heart development (Nolte et al., 2013). Exog-
enous expression of the hoxb2–b4 genes rescues only about
39.45% of the Flk1+ mesoderm population, but not the cardiac
lineage, suggesting that HoxBlinc primarily regulates hemangio-
genic/cardiogenic mesoderm specification, but not cardiac dif-
ferentiation, by coordinating anterior hoxb gene expression.
Chromatin looping plays a central role in regulating long-range
transcription activation, chromatin insulation, and imprinted
gene expression (Handoko et al., 2011; Li et al., 2012; Sanyal
et al., 2012; Wallace and Felsenfeld, 2007). Although active his-
tone modifications such as H3 acetylation and H3K4 methyla-
tions are implicated in the communication between genes and112 Cell Reports 14, 103–114, January 5, 2016 ª2016 The Authorsdistal cis-regulatory elements (Andreu-Vieyra et al., 2010; Patel
et al., 2014), it was suggested that sequence-specific TFs initiate
contacts between regulatory elements (Deng et al., 2012; Song
et al., 2007). Our data revealed that HoxBlinc RNA also directs
chromatin loop formation (Figure 6H). HoxBlinc-mediated chro-
matin loops may have several important functions in maintaining
locus-specific H3K4me3 and Hox gene activation. First, the
looping could aid in distributing HoxBlinc RNA and epigenetic
regulators to anterior hoxb genes. Second, looping between
two ctcf sites that flank hoxb1 and hoxb4 genes establishes a dif-
ferentiation-specific active chromatin domain and separates the
active anterior and silent posterior chromatin domains. Finally,
looping brings theHoxBlinc locus in close proximity with anterior
hoxb genes for transcription activation by controlling local chro-
matin structure (Figure 6). Obviously, Hox clusters are com-
pound genomic loci that contain many regulatory DNA elements.
Regulation of theHox gene loci involves complicated processes,
which may include formation of various chromatin loops during
different development stages. Although our study did not rule
out the possibility that other regulatory elements in the locus
may also be required for anterior hoxb activation, we demon-
strated that the interactions between the HoxBlinc locus and
the anterior hoxb promoters are mediated by HoxBlinc RNA.
Thus, our data reveal important and general mechanisms by
which HoxBlinc RNA modulates local chromatin structure to
control lineage specification and differentiation during
development.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures. All experiments were performed according to the guide-
lines of the institutional animal care and use committee of The University of
Florida.
Generation of Inducible KD and CRISPR-Cas9 KO Cell Lines, In Vitro
Differentiation, and Teratoma Assays
Murine ESC lines, R1/E (ATCC SCRC-1036), and CGR8MHC-GFPwere main-
tained as previously described (Deng et al., 2013). The differentiation of he-
matopoietic/cardiac cells, BL-CFC, and colony-forming cell (CFC) assays of
ESCs were performed as previously described (Choi et al., 1998; Kennedy
et al., 1997; Lancrin et al., 2009; Shen and Qu, 2008; Sroczynska et al.,
2009) with minor modifications. The teratoma assay was performed as previ-
ously described (Nelakanti et al., 2015). For FACS analysis, single-cell suspen-
sions obtained from differentiated EBs were subjected to FACS analysis using
antibodies against FLK-1 APC or CD117 PE (c-Kit) and CD41 FITC (BD Biosci-
ences). Data analysis was performed using a BD LSRII system (BD
Biosciences).
Northern Blot and qRT-PCR
Total RNAwas prepared by using the RNeasymini isolation kit according to the
manufacturer’s instruction (QIAGEN). Two micrograms of RNA was reverse
transcribed using ProtoScript II Reverse Transcriptase (New England Biolabs).
cDNA was analyzed by real-time PCR (qRT-PCR) using the SYBR Green PCR
master mix and the Bio-Rad CFX96 system (Bio-Rad). Primer and probe se-
quences are listed in the Supplemental Information (Table S3).
RNA Sequencing and Data Analysis
Paired-end RNA-seq was performed by Otogenetics according to standard
protocols. The sequence reads have been deposited in the NCBI Short
Read Archive (GSE74894). Data analysis was provided in the Supplemental
Experimental Procedures.
Generation of Biotinylated RNA, Pull-Down Assay, and RIP
BiotinylatedHoxBlinc and control RNAswere generated using the AmpliScripe
T7-Flash Transcription Kit (Epicenter) according to the manufacturer’s instruc-
tions. Pull-down assay and RIP were performed as described previously
(Wang et al., 2011).
BoxB-Tethering Reporter Assay
23 105 K562 cells were seeded into 24-well plates 12 hr prior to transfections.
Cells were transfected with plasmids encoding a luciferase gene under the
control of five tandem GAL4 UAS sites, GAL4-lN (the 22-amino-acid RNA-
binding domain of the lambda bacteriophage anti-terminator protein N),
BoxB (containing five repeats of the lN-specific 19-nucleotide-binding site),
or BoxB fused to full-length HoxBlinc or siRNAs specifically targeting ASH2L
or LSD1. Transfected cells were collected and analyzed by luciferase reporter
gene activities 48 hr after transfection using a luciferase assay kit (Promega).
ChIP, ChIRP, and 3C Assays
ChIP assays were performed as described previously (Li et al., 2011). The
ChIRP assay was performed according to a protocol described in a previous
study (Chu et al., 2011) with some modifications. Antibodies, probes, and
primers are listed in the Supplemental Information.
3C assay was performed as previously described (Andreu-Vieyra et al.,
2010; Patel et al., 2014) with minor modifications. In brief, chromatin from
2 3 106 cross-linked cells were digested with 800 U of EcoRI overnight and
subjected to ligation in a 6-ml volume at 16C for 3 days followed by 60 min
at room temperature. The 3C-ligated DNA was purified and amplified using
PCR, and the products were cloned into pGEM T easy vector (Promega) for
sequencing. Primers are listed in the Supplemental Information.
ACCESSION NUMBERS
The accession number for the sequence reads reported in this paper is NCBI
SRA: GSE74894.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, three tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2015.12.007.
ACKNOWLEDGMENTS
Wewould like to thank Drs. HowardChang, Jianrong Lu, and James J. Hsieh for
providing reagents.WethankDr.GraigG.Moneypenny forassistingwithflowcy-
tometry. This work was supported by grants from the NIH (S.H., R56DK101994;
Y.Q., R01HL095674; J.B., R01DK52356; and L.Z., R01GM106174).
Received: December 2, 2014
Revised: August 26, 2015
Accepted: November 22, 2015
Published: December 24, 2015
REFERENCES
Abramovich, C., and Humphries, R.K. (2005). Hox regulation of normal and
leukemic hematopoietic stem cells. Curr. Opin. Hematol. 12, 210–216.
Andreu-Vieyra, C.V., Chen, R., Agno, J.E., Glaser, S., Anastassiadis, K., Stew-
art, A.F., and Matzuk, M.M. (2010). MLL2 is required in oocytes for bulk
histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol. 8,
pii: e1000453.
Benveniste, P., Serra, P., Dervovic, D., Herer, E., Knowles, G., Mohtashami,
M., and Zu´n˜iga-Pfl€ucker, J.C. (2014). Notch signals are required for in vitro
but not in vivo maintenance of human hematopoietic stem cells and delay
the appearance of multipotent progenitors. Blood 123, 1167–1177.
Bertani, S., Sauer, S., Bolotin, E., and Sauer, F. (2015). Retraction. Mol. Cell
57, 572.CBigas, A., and Espinosa, L. (2012). Hematopoietic stem cells: to be or Notch to
be. Blood 119, 3226–3235.
Bjo¨rnsson, J.M., Larsson, N., Brun, A.C., Magnusson, M., Andersson, E.,
Lundstro¨m, P., Larsson, J., Repetowska, E., Ehinger, M., Humphries, R.K.,
and Karlsson, S. (2003). Reduced proliferative capacity of hematopoietic
stem cells deficient in Hoxb3 and Hoxb4. Mol. Cell. Biol. 23, 3872–3883.
Blank, U., Karlsson, G., and Karlsson, S. (2008). Signaling pathways governing
stem-cell fate. Blood 111, 492–503.
Brock, H.W., Hodgson, J.W., Petruk, S., and Mazo, A. (2009). Regulatory non-
coding RNAs at Hox loci. Biochem. Cell Biol. 87, 27–34.
Chambeyron, S., and Bickmore, W.A. (2004). Chromatin decondensation and
nuclear reorganization of the HoxB locus upon induction of transcription.
Genes Dev. 18, 1119–1130.
Chambeyron, S., Da Silva, N.R., Lawson, K.A., and Bickmore, W.A. (2005).
Nuclear re-organisation of the Hoxb complex during mouse embryonic devel-
opment. Development 132, 2215–2223.
Chan, S.S., Shi, X., Toyama, A., Arpke, R.W., Dandapat, A., Iacovino,M., Kang,
J., Le, G., Hagen, H.R., Garry, D.J., and Kyba, M. (2013). Mesp1 patterns
mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in
a context-dependent manner. Cell Stem Cell 12, 587–601.
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J.C., and Keller, G. (1998).
A common precursor for hematopoietic and endothelial cells. Development
125, 725–732.
Chu, C., Qu, K., Zhong, F.L., Artandi, S.E., and Chang, H.Y. (2011). Genomic
maps of long noncoding RNA occupancy reveal principles of RNA-chromatin
interactions. Mol. Cell 44, 667–678.
Chung, Y.S., Zhang, W.J., Arentson, E., Kingsley, P.D., Palis, J., and Choi, K.
(2002). Lineage analysis of the hemangioblast as defined by FLK1 and SCL
expression. Development 129, 5511–5520.
Davidovich, C., Zheng, L., Goodrich, K.J., and Cech, T.R. (2013). Promiscuous
RNA binding by Polycomb repressive complex 2. Nat. Struct. Mol. Biol. 20,
1250–1257.
Deng, W., Lee, J., Wang, H., Miller, J., Reik, A., Gregory, P.D., Dean, A., and
Blobel, G.A. (2012). Controlling long-range genomic interactions at a native lo-
cus by targeted tethering of a looping factor. Cell 149, 1233–1244.
Deng, C., Li, Y., Liang, S., Cui, K., Salz, T., Yang, H., Tang, Z., Gallagher, P.G.,
Qiu, Y., Roeder, R., et al. (2013). USF1 and hSET1Amediated epigenetic mod-
ifications regulate lineage differentiation and HoxB4 transcription. PLoS
Genet. 9, e1003524.
Ema, M., Faloon, P., Zhang, W.J., Hirashima, M., Reid, T., Stanford, W.L.,
Orkin, S., Choi, K., and Rossant, J. (2003). Combinatorial effects of Flk1 and
Tal1 on vascular and hematopoietic development in the mouse. Genes Dev.
17, 380–393.
Ernst, P., Fisher, J.K., Avery, W., Wade, S., Foy, D., and Korsmeyer, S.J.
(2004). Definitive hematopoiesis requires the mixed-lineage leukemia gene.
Dev. Cell 6, 437–443.
Grote, P., Wittler, L., Hendrix, D., Koch, F., Wa¨hrisch, S., Beisaw, A., Macura,
K., Bla¨ss, G., Kellis, M., Werber, M., and Herrmann, B.G. (2013). The tissue-
specific lncRNA Fendrr is an essential regulator of heart and body wall
development in the mouse. Dev. Cell 24, 206–214.
Guttman,M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M.,
Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals
over a thousand highly conserved large non-coding RNAs inmammals. Nature
458, 223–227.
Guttman, M., Donaghey, J., Carey, B.W., Garber, M., Grenier, J.K., Munson,
G., Young, G., Lucas, A.B., Ach, R., Bruhn, L., et al. (2011). lincRNAs act in
the circuitry controlling pluripotency and differentiation. Nature 477, 295–300.
Handoko, L., Xu, H., Li, G., Ngan, C.Y., Chew, E., Schnapp, M., Lee, C.W., Ye,
C., Ping, J.L., Mulawadi, F., et al. (2011). CTCF-mediated functional chromatin
interactome in pluripotent cells. Nat. Genet. 43, 630–638.
Hu, G., Tang, Q., Sharma, S., Yu, F., Escobar, T.M., Muljo, S.A., Zhu, J., and
Zhao, K. (2013). Expression and regulation of intergenic long noncoding RNAs
during T cell development and differentiation. Nat. Immunol. 14, 1190–1198.ell Reports 14, 103–114, January 5, 2016 ª2016 The Authors 113
Huang, H.T., Kathrein, K.L., Barton, A., Gitlin, Z., Huang, Y.H., Ward, T.P., Hof-
mann, O., Dibiase, A., Song, A., Tyekucheva, S., et al. (2013). A network of
epigenetic regulators guides developmental haematopoiesis in vivo. Nat.
Cell Biol. 15, 1516–1525.
Iimura, T., and Pourquie´, O. (2006). Collinear activation of Hoxb genes during
gastrulation is linked to mesoderm cell ingression. Nature 442, 568–571.
Katsani, K.R., Arredondo, J.J., Kal, A.J., and Verrijzer, C.P. (2001). A homeotic
mutation in the trithorax SET domain impedes histone binding. Genes Dev. 15,
2197–2202.
Kattman, S.J., Huber, T.L., and Keller, G.M. (2006). Multipotent flk-1+ cardio-
vascular progenitor cells give rise to the cardiomyocyte, endothelial, and
vascular smooth muscle lineages. Dev. Cell 11, 723–732.
Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N., and Kel-
ler, G. (1997). A common precursor for primitive erythropoiesis and definitive
haematopoiesis. Nature 386, 488–493.
Khalil, A.M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D.,
Thomas, K., Presser, A., Bernstein, B.E., van Oudenaarden, A., et al. (2009).
Many human large intergenic noncoding RNAs associate with chromatin-
modifying complexes and affect gene expression. Proc. Natl. Acad. Sci.
USA 106, 11667–11672.
Klattenhoff, C.A., Scheuermann, J.C., Surface, L.E., Bradley, R.K., Fields, P.A.,
Steinhauser, M.L., Ding, H., Butty, V.L., Torrey, L., Haas, S., et al. (2013).
Braveheart, a long noncoding RNA required for cardiovascular lineage
commitment. Cell 152, 570–583.
Krumlauf, R. (1994). Hox genes in vertebrate development. Cell 78, 191–201.
Lancrin, C., Sroczynska, P., Stephenson, C., Allen, T., Kouskoff, V., and
Lacaud, G. (2009). The haemangioblast generates haematopoietic cells
through a haemogenic endothelium stage. Nature 457, 892–895.
Lawrence, H.J., Sauvageau, G., Humphries, R.K., and Largman, C. (1996). The
role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem
Cells 14, 281–291.
Lengerke, C., Schmitt, S., Bowman, T.V., Jang, I.H., Maouche-Chretien, L.,
McKinney-Freeman, S., Davidson, A.J., Hammerschmidt, M., Rentzsch, F.,
Green, J.B., et al. (2008). BMP and Wnt specify hematopoietic fate by activa-
tion of the Cdx-Hox pathway. Cell Stem Cell 2, 72–82.
Li, X.,Wang, S., Li, Y., Deng, C., Steiner, L.A., Xiao, H.,Wu, C., Bungert, J., Gal-
lagher, P.G., Felsenfeld, G., et al. (2011). Chromatin boundaries require func-
tional collaboration between the hSET1 and NURF complexes. Blood 118,
1386–1394.
Li, G., Ruan, X., Auerbach, R.K., Sandhu, K.S., Zheng, M., Wang, P., Poh,
H.M., Goh, Y., Lim, J., Zhang, J., et al. (2012). Extensive promoter-centered
chromatin interactions provide a topological basis for transcription regulation.
Cell 148, 84–98.
Liu, H.C., Shih, L.Y., May Chen, M.J., Wang, C.C., Yeh, T.C., Lin, T.H., Chen,
C.Y., Lin, C.J., and Liang, D.C. (2011). Expression of HOXB genes is signifi-
cantly different in acute myeloid leukemia with a partial tandem duplication
of MLL vs. a MLL translocation: a cross-laboratory study. Cancer Genet.
204, 252–259.
Liu, F., Kang, I., Park, C., Chang, L.W., Wang, W., Lee, D., Lim, D.S., Vittet, D.,
Nerbonne, J.M., and Choi, K. (2012). ER71 specifies Flk-1+ hemangiogenic
mesoderm by inhibiting cardiac mesoderm and Wnt signaling. Blood 119,
3295–3305.
Loewer, S., Cabili, M.N., Guttman, M., Loh, Y.H., Thomas, K., Park, I.H.,
Garber, M., Curran, M., Onder, T., Agarwal, S., et al. (2010). Large intergenic
non-coding RNA-RoR modulates reprogramming of human induced pluripo-
tent stem cells. Nat. Genet. 42, 1113–1117.
Magnusson, M., Brun, A.C., Lawrence, H.J., and Karlsson, S. (2007). Hoxa9/
hoxb3/hoxb4 compound null mice display severe hematopoietic defects.
Exp. Hematol. 35, 1421–1428.
Nelakanti, R.V., Kooreman, N.G., and Wu, J.C. (2015). Teratoma formation: a
tool for monitoring pluripotency in stem cell research. Curr. Protoc. Stem Cell
Biol. 32, 4A.8.1–4A.8.17.114 Cell Reports 14, 103–114, January 5, 2016 ª2016 The AuthorsNiessen, K., and Karsan, A. (2008). Notch signaling in cardiac development.
Circ. Res. 102, 1169–1181.
Nolte, C., Jinks, T., Wang, X., Martinez Pastor, M.T., and Krumlauf, R. (2013).
Shadow enhancers flanking the HoxB cluster direct dynamic Hox expression
in early heart and endoderm development. Dev. Biol. 383, 158–173.
Oh, P., Lobry, C., Gao, J., Tikhonova, A., Loizou, E., Manent, J., van Handel, B.,
Ibrahim, S., Greve, J., Mikkola, H., et al. (2013). In vivo mapping of notch
pathway activity in normal and stress hematopoiesis. Cell Stem Cell 13,
190–204.
Olson, E.N. (2006). Gene regulatory networks in the evolution and develop-
ment of the heart. Science 313, 1922–1927.
Oshima, M., Endoh, M., Endo, T.A., Toyoda, T., Nakajima-Takagi, Y., Su-
giyama, F., Koseki, H., Kyba, M., Iwama, A., and Osawa, M. (2011).
Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic
stem and progenitor cells developing from embryonic stem cells. Blood 117,
e142–e150.
Patel, B., Kang, Y., Cui, K., Litt, M., Riberio, M.S., Deng, C., Salz, T., Casada,
S., Fu, X., Qiu, Y., et al. (2014). Aberrant TAL1 activation is mediated by an
interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Leukemia 28, 349–361.
Pindyurin, A.V., and van Steensel, B. (2012). Hox in space: gene cluster regu-
lation linked to folding of chromatin. Nucleus 3, 118–122.
Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A.,
Goodnough, L.H., Helms, J.A., Farnham, P.J., Segal, E., and Chang, H.Y.
(2007). Functional demarcation of active and silent chromatin domains in hu-
man HOX loci by noncoding RNAs. Cell 129, 1311–1323.
Rozenblatt-Rosen, O., Rozovskaia, T., Burakov, D., Sedkov, Y., Tillib, S.,
Blechman, J., Nakamura, T., Croce, C.M., Mazo, A., and Canaani, E. (1998).
The C-terminal SET domains of ALL-1 and TRITHORAX interact with the
INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc. Natl.
Acad. Sci. USA 95, 4152–4157.
Sanyal, A., Lajoie, B.R., Jain, G., and Dekker, J. (2012). The long-range inter-
action landscape of gene promoters. Nature 489, 109–113.
Shen, J., and Qu, C.K. (2008). In vitro hematopoietic differentiation of murine
embryonic stem cells. Methods Mol. Biol. 430, 103–118.
Singh, A.M., Li, F.Q., Hamazaki, T., Kasahara, H., Takemaru, K., and Terada,
N. (2007). Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates
cardiomyocyte differentiation of murine embryonic stem cells. Circulation
115, 617–626.
Song, S.H., Hou, C., and Dean, A. (2007). A positive role for NLI/Ldb1 in long-
range beta-globin locus control region function. Mol. Cell 28, 810–822.
Soshnikova, N., and Duboule, D. (2009). Epigenetic temporal control of mouse
Hox genes in vivo. Science 324, 1320–1323.
Sroczynska, P., Lancrin, C., Pearson, S., Kouskoff, V., and Lacaud, G. (2009).
In vitro differentiation of mouse embryonic stem cells as a model of early he-
matopoietic development. Methods Mol. Biol. 538, 317–334.
Trompouki, E., Bowman, T.V., Lawton, L.N., Fan, Z.P., Wu, D.C., DiBiase, A.,
Martin, C.S., Cech, J.N., Sessa, A.K., Leblanc, J.L., et al. (2011). Lineage reg-
ulators direct BMP and Wnt pathways to cell-specific programs during differ-
entiation and regeneration. Cell 147, 577–589.
Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi,
Y., Segal, E., and Chang, H.Y. (2010). Long noncoding RNA as modular scaf-
fold of histone modification complexes. Science 329, 689–693.
Wallace, J.A., and Felsenfeld, G. (2007). We gather together: insulators and
genome organization. Curr. Opin. Genet. Dev. 17, 400–407.
Wang, K.C., Yang, Y.W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y.,
Lajoie, B.R., Protacio, A., Flynn, R.A., Gupta, R.A., et al. (2011). A long noncod-
ing RNA maintains active chromatin to coordinate homeotic gene expression.
Nature 472, 120–124.
Watanabe, Y., and Buckingham, M. (2010). The formation of the embryonic
mouse heart: heart fields and myocardial cell lineages. Ann. N Y Acad. Sci.
1188, 15–24.
